- 2183人
- 分享收藏
舒颜萃(注射用聚左旋乳酸)
Sculptra (Injectable Poly-L-Lactic Acid)
简介
【 文献重点摘要 】
As contemporary antiviral therapy provides patients who have HIV effective long-term management of their disease, the prevalence of HIV-associated lipoatrophy is increasing. Sculptra (injectable poly-L-lactic acid) is FDA approved for the treatment of HIV-associated lipoatrophy and has been shown to increase skin thickness for up to 2 years. The number of treatment sessions depends on the volume of deficiency to be treated. As is true for any cosmetic treatment, expectations must be carefully managed, especially considering the common need for multiple Sculptra treatments.
随着现代抗病毒治疗为艾滋病病毒携带者提供有效的长期治疗，艾滋病病毒相关性脂肪萎缩的患病率正在增加。舒颜萃(注射用聚左旋乳酸)被FDA批准用于治疗HIV相关的脂肪萎缩，并已被证明可增加皮肤厚度长达2年。治疗疗程的数量取决于要治疗的缺乏量。就像任何美容治疗一样，期望必须仔细管理，特别是考虑到对多种舒颜萃治疗的共同需求。
学习目录
学员评价
DMCAS学习顾问
资料研究员
文献包 - 【聚左旋乳酸】 PLLA
198.00
注射用聚左旋乳酸改善皮肤质量的随机对照多中心双盲研究
19.90
聚左旋乳酸治疗面部不对称的病例研究
19.90
软组织增大术与聚左旋乳酸的作用
19.90
舒颜萃®的安全性：临床试验数据回顾
19.90
使用舒颜萃进行软组织增大术
19.90